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Background: Post-ischemic myocardial remodeling (PIR) determines the degree of left-ventricular dysfunction and mortality after acute myocardial 
infarction (AMI). Previous gene- and cell-based methods, e.g. the delivery of insulin-like-growth-factor-1 (IGF-1) after myocardial revascularization, 
demonstrated amelioration of PIR. We aimed to evaluate transthoracic ultrasound mediated microbubble stimulation (UMS) for gene- and cell-free 
treatment of AMI.
Methods: UMS was administered with commercially available microbubbles (Sonovue™, Bracco Inc.) in a closed-chest mouse model of AMI 
as post-conditioning (PC) in the beginning of myocardial reperfusion. Global and regional systolic left-ventricular morphology and function were 
measured with high-resolution reconstructive 3D-echocardiography (r3D-echo) during ischemia as well as at rest and during low-dose dobutamine 
after 2 weeks. Further, RNA- and protein-levels of IGF-1, as well as quantification of scar size with histomorphometry were conducted.
Results: A total of 46 C57bl6 mice were investigated, of which 22 received PC with UMS. Mean EF during ischemia was similar in the treatment 
groups (53% +/- 10 (-UMS) and 48% +/- 15 (+UMS), p=0.5), reflecting comparable myocardial mass at risk (17% +/- 8 (-UMS), 22% +/- 14 
(+UMS)). Two weeks after AMI and reperfusion, mice undergoing UMS demonstrated significantly better left-ventricular function (52% +/- 11) as 
compared to the group without PC (39% +/- 11, p<0.01). In parallel, akinetic myocardial mass was significantly lower in the UMS group (27% +/- 10 
(-UMS), 13% +/- 15 (+UMS), p<0.05). Further, UMS-treated animals had significantly better regional left-ventricular function and contractile reserve, 
as a measure of myocardial viability. Subgroup analysis revealed that UMS effect is independent of the extent of myocardial ischemia at baseline. 
Real-time PCR and ELISA revealed UMS-dependent upregulation of IGF-1 as a potential mechanism of PC. Ultimately, quantitative histomorphometry 
confirmed significant decrease of scar size related to PC with UMS.
Conclusions: UMS following AMI and reperfusion results in improved left-ventricular function and decrease of scar size in mice.
